<DOC>
	<DOC>NCT00108368</DOC>
	<brief_summary>The goal of this research is to find ways to maximize the benefits of antipsychotic medications for cognition. Hypothesis: Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition, particularly affect perception and social perception.</brief_summary>
	<brief_title>The Effects of Risperidone and Olanzapine on Thinking</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Diagnosed with schizophrenia disorder by a DSM IV. Competent to sign informed consent No history of poor response to Risperdal and Zyprexa No organic brain disease Mental retardation or any chronic medical illness which results in the patient not being appropriate for a switch to Risperdal or Zyprexa.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>cognition</keyword>
	<keyword>antipsychotic medication</keyword>
	<keyword>information processing</keyword>
	<keyword>social cognition</keyword>
	<keyword>Psychotic</keyword>
</DOC>